二十碳五烯酸
内科学
肌萎缩
内分泌学
骨骼肌
胰岛素抵抗
线粒体生物发生
SIRT3
2型糖尿病
医学
葡萄糖稳态
氧化应激
肌生成抑制素
肌肉萎缩
线粒体
2型糖尿病
糖基化
萎缩
细胞凋亡
胰岛素
糖基化终产物
葡萄糖摄取
药理学
平衡
TXNIP公司
糖尿病
氧化磷酸化
血糖性
欧米茄3脂肪酸
化学
合成代谢
C2C12型
β氧化
脂联素
浪费的
作者
Shi-Xiang Wu,Meng-qing Zhou,Han-Ni Wei,Yan Zheng,Zi-Jian Wu,Xin-Yue Zhao,Qing-Yan Zou,Cheng-Yu Yang,Ao Tian,Yuhong Yang,Changsheng Zhao,Lei Du
标识
DOI:10.1021/acs.jafc.5c11649
摘要
This study investigated the therapeutic potential of eicosapentaenoic acid (EPA) against type 2 diabetes mellitus (T2DM)-related sarcopenia. In a streptozotocin/high-fat diet-induced T2DM mouse model, 24 week EPA supplementation improved insulin resistance, reduced advanced glycation end product (AGE) accumulation, and preserved skeletal muscle mass and strength. In vitro, the EPA mitigated high-glucose/AGE-induced atrophy in C2C12 myotubes. Mechanistically, EPA counteracted T2DM-related sarcopenia through improving insulin resistance and glycemic control, lowering AGE accumulation, and attenuating inflammatory response and oxidative damage in skeletal muscle. Moreover, EPA protected mitochondrial integrity in skeletal muscle cells by activating the AMPK/Sirt1/PGC-1α axis to boost mitochondrial biogenesis and alleviated excessive apoptosis via inhibiting the intrinsic apoptotic pathway. Furthermore, the EPA maintained protein metabolic homeostasis in skeletal muscle via restoring the PI3K/Akt/mTOR signaling cascade and suppressing the FoxO3a- and NF-κB-mediated ubiquitin-proteasome pathway. Overall, our findings suggest EPA as a promising nutritional intervention against T2DM-related sarcopenia.
科研通智能强力驱动
Strongly Powered by AbleSci AI